Miramar Capital, LLC Eli Lilly & CO Transaction History

Miramar Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $17,537 - $23,449	-50 Reduced 2.08%	2,352 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $3,261 - $3,716	11 Added 0.46%	2,402 $873,000
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $19,232 - $22,581	-69 Reduced 2.8%	2,391 $775,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $256,281 - $318,492	1,092 Added 79.82%	2,460 $704,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $11,242 - $13,952	-50 Reduced 3.53%	1,368 $378,000
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $216,298 - $279,780	-1,198 Reduced 45.8%	1,418 $375,000
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $396,011 - $512,655	-2,410 Reduced 47.95%	2,616 $489,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $655,691 - $867,638	5,026 New	5,026 $1.03 Million

4,031

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Miramar Capital, LLC with notifications on news.